Preferred Label : Ertapenem;

MeSH definition : A carbapenem derivative antibacterial agent that is more stable to renal dehydropeptidase I than IMIPENEM, but does not need to be given with an enzyme inhibitor such as CILASTATIN. It is used in the treatment of Gram-positive and Gram-negative bacterial infections including intra-abdominal infections, acute gynecological infections, complicated urinary tract infections, skin infections, and respiratory tract infections. It is also used to prevent infection in colorectal surgery.;

MeSH CAS label : (4R,5R,6S)-3-((3S,5S)-5-((3-Carboxyphenyl)carbamoyl)pyrrolidin-3-yl)sulfanyl-6-(1-hydroxyethyl)-4-methyl-7-oxo-1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid;

MeSH Related Number : 2T90KE67L0;

Wikipedia link : https://en.wikipedia.org/wiki/Ertapenem;

UNII : G32F6EID2H;

Details


Main resources

You can consult :

A carbapenem derivative antibacterial agent that is more stable to renal dehydropeptidase I than IMIPENEM, but does not need to be given with an enzyme inhibitor such as CILASTATIN. It is used in the treatment of Gram-positive and Gram-negative bacterial infections including intra-abdominal infections, acute gynecological infections, complicated urinary tract infections, skin infections, and respiratory tract infections. It is also used to prevent infection in colorectal surgery.

https://www.ema.europa.eu/en/medicines/human/EPAR/ertapenem-sun
2022
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
Ertapenem
Ertapenem
drugs, generic
drug approval
europe
anti-bacterial agents
anti-bacterial agents
ertapenem
adult
infant
child
adolescent
intraabdominal infections
community-acquired infections
pneumonia, bacterial
gynecological infection
Diabetic foot infection
reproductive tract infections
antibiotic prophylaxis
surgical wound infection
infusions, intravenous
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical

---
https://www.has-sante.fr/portail/jcms/c_2881398/fr/ertapenem-arrow
2018
false
false
false
France
evaluation of the transparency committee
Ertapenem

---
https://www.has-sante.fr/portail/jcms/c_2868356/fr/ertapenem-hikma
2018
false
false
false
false
France
French
evaluation of the transparency committee
drugs, generic
beta-Lactams
Ertapenem

---
https://www.has-sante.fr/portail/jcms/c_2814675/fr/ertapenem-fresenius-kabi
2017
false
false
false
France
French
evaluation of the transparency committee
beta-Lactams
Ertapenem

---
https://www.has-sante.fr/portail/jcms/c_2821750/fr/ertapenem-panpharma
2017
false
false
false
France
French
evaluation of the transparency committee
beta-Lactams
Ertapenem

---
https://www.ema.europa.eu/medicines/human/EPAR/Invanz
2012
United Kingdom
French
English
syndication feed
antibiotic therapy
anti-bacterial agents
anti-bacterial agents
treatment outcome
drug evaluation
infusions, intravenous
adult
infant
child
drug approval
drug labeling
carbapenems
community-acquired infections
pelvic infection
pneumonia
diabetic foot
adolescent
Infections
abdomen
surgical wound infection
antibiotic prophylaxis
colorectal surgery
pregnancy
breast feeding
ertapenem
ertapenem sodium
ertapenem sodium
summary of product characteristics
drug evaluation
package leaflet
Ertapenem
Ertapenem
beta-Lactams
beta-Lactams

---
http://www.lecrat.eu/?s=Ertap%C3%A9nem
2009
France
French
antibiotic therapy
pregnancy
anti-bacterial agents
ertapenem
ertapenem sodium
drug information
Ertapenem
beta-Lactams

---
https://www.cadth.ca/sites/default/files/pdf/108_No25_ertapenem_edrug_f.pdf
2002
Canada
French
antibiotic therapy
bacterial infections
beta-Lactams
anti-bacterial agents
ertapenem
beta-Lactams
drug evaluation
Ertapenem

---
Nous contacter.
05/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.